Latest News and Press Releases

Le venglustat de Sanofi a atteint tous les critères d'évaluation principaux dans une étude de phase 3 sur la maladie de Gaucher de type 3 Dans l’étude de phase 3 LEAP2MONO, le venglustat, administré...

Sanofi's investigational drug venglustat improved the neurologic symptoms of type 3 Gaucher disease, for which there are currently no approved therapies.

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "GCP (Good Clinical Practice) and Clinical Research Update - Hot Inspection Topics Training Course (May 19, 2026)" training has been added to ...

Kelly McKee to help shape Science 37’s future patient experience, driving growth through modernized trials, innovation, and cross-team collaboration.

Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Decentralized Clinical Trials Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. Decentralized...

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Supplies Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The clinical trial...

Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "Microbiology Culture Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering.The global microbiology culture market size is...

Dublin, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The "Clinical Research Project Management Training Course (April 29, 2026 and May 1, 2026)" has been added to ResearchAndMarkets.com's offering. Setting...

Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Patient Recruitment Services Market Size, Share & Trends Analysis Report by Service (Patient Recruitment & Registry Services,...

American Oncology Research and MiBA Form Strategic Alliance to Integrate Real-Time Data Intelligence with Community-Based Clinical Research